Go & Express

Immunotherapy

Latest news & developments
KEYTRUDA® was approved in 2017 to treat metastatic melanoma and advanced lung cancer. it has now been approved for first-line treatment of advanced lung cancer and for first-line and second-line treatment of advanced bladder cancer.                                                                                                                                      Image: 123RF/ILLIA URIADNIKOV
BLADDER CANCER

Approval of breakthrough cancer medicine will offer ‘renewed hope’

The approval of a cancer drug for a wider range of conditions has been hailed as an “offer of renewed hope” for SA patients battling the dreaded disease. KEYTRUDA®, previously used to treat certain types of skin and lung cancers, has been…

  • TimesLIVE